ASND β€” ASCENDIS PHARMA A S

Ownership history in Avidity Partners Management LP  Β·  4 quarters on record

AI Ownership Summary

Avidity Partners Management LP reported ASCENDIS PHARMA A S (ASND) in 4 quarterly 13F filings from 2024 Q3 through 2025 Q3. Peak portfolio weight reached 0.91% in 2024 Q3. The latest visible filing shows ASND at 0.66% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this ASND ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Avidity Partners Management LP's position in ASCENDIS PHARMA A S, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q3

ASND was reported at 0.66% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.91% in 2024 Q3

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q3 to 2025 Q3

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

ASND stock page Avidity Partners Management LP fund profile Avidity Partners Management LP full holdings
How Avidity Partners Management LP held ASND β€” position size vs. price
% of Fund (quarterly)    ASND price (quarter-end, indexed to 100)
πŸ“‹ Quarterly Holdings History 3 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q3 REDUCED 14,500 -47,500 -76.6% 0.66% $2.9M 2025-11-14 $204.40
2024 Q4 REDUCED 62,000 -57,000 -47.9% 0.84% $8.5M 2025-02-14 $144.08
2024 Q3 ADDED 119,000 +100 +0.1% 0.91% $17.8M 2024-11-14 $124.28
1 older quarter hidden  β€”  Sign in free or upgrade to Premium to see full history

🏒 Other funds also holding ASND

As of 2025 Q4 β€” sorted by position size

Q Global Advisors, LLC 3Y 7Y 39.86% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 22.46% Avoro Capital Advisors LLC 3Y 7Y 10.71% Resolute Capital Asset Partners LLC 3Y 9.13% Tri Locum Partners LP 3Y 7.34% WESTFIELD CAPITAL MANAGEMENT CO LP 3Y 7Y 4.61% Catalio Capital Management, LP 4.49% Spyglass Capital Management LLC 3Y 7Y 4.43% PERCEPTIVE ADVISORS LLC 3Y 7Y 4.11% PFM Health Sciences, LP 3Y 7Y 3.78%

FAQ About Avidity Partners Management LP and ASND

These are the practical questions this page is built to answer before you even open the full history table.

How long has Avidity Partners Management LP reported owning ASND?

Avidity Partners Management LP reported ASND across 3 quarterly 13F filings, from 2024 Q3 through 2025 Q3.

What was the largest reported ASND position in Avidity Partners Management LP's portfolio?

The largest reported portfolio weight for ASND was 0.91% in 2024 Q3.

What is the latest reported ASND position on this page?

The most recent filing on this page is 2025 Q3, when Avidity Partners Management LP reported 14,500 shares, equal to 0.66% of portfolio, with an estimated market value of $2.9M.

What does the chart on this ASND ownership page compare?

The chart compares Avidity Partners Management LP's quarterly ASND portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to Avidity Partners Management LP Holdings